POZ

Search POZ

Adding Sovaldi and Ribavirin to Retreatment With Mavyret Beats Hep C

Mar 21, 2018: Those for whom Mavyret did not work the first time had a high cure rate with this intensified retreatment regimen.

AbbVie’s Hep C Regimens Are Safe for Those With Milder Cirrhosis

Oct 18, 2017: This finding applies to those with Child-Pugh A cirrhosis who are treated with the Viekira regimen or Technivie, with or without ribavirin.

Real-World Hepatitis C Cure Rates Are Excellent in Europeans With HIV

Apr 25, 2018: In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C.

Among Those With HIV, Certain Factors Lower Chance of Curing Hep C

Feb 5, 2018: These include a low CD4 count, having cirrhosis and taking certain hep C drug regimens.

Cirrhosis Is Linked With Hep C Treatment Failure Among Those Who Also Have HIV

Sep 6, 2017: Researchers identified this association after looking at real-world data on a large group of German individuals with HIV and hep C.

FDA OKs AbbVie’s Mavyret for All Hepatitis C Genotypes

Aug 3, 2017: The two-drug regimen can cure the virus in as little as eight weeks.

AbbVie’s Viekira Is Likely Safe for Kidneys in Those With HIV and Hep C

Mar 27, 2018: A recent study analyzed kidney parameters among those with HIV who were treated for hep C with the regimen.

Eight Weeks of Technivie Is Highly Effective in Treating Hepatitis C

Jun 13, 2018: This was among a small group of people who contracted the virus within one year, most of whom had HIV as well.

How Well Do Docs Manage Potential Conflicts Between Hep C and HIV Meds?

Apr 9, 2018: A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.

Chance of Curing Hep C Is Lower Among Some Living With HIV

May 14, 2018: People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.

Hep C Treatment Program Cuts Prevalence by Two Thirds in Swiss HIV Cohort

Nov 8, 2017: The ongoing cohort of men who have sex with men living with HIV had a hep C prevalence rate of about 5 percent.

Epclusa Cures Hepatitis C at a High Rate Regardless of HIV Status

Apr 23, 2018: Additionally, in a recent study, having hep C mutations associated with resistance didn’t affect the outcome of treatment.

Eight Weeks of Mavyret Is Highly Effective at Treating Hepatitis C

Apr 18, 2018: Among those without cirrhosis, treating for an additional four weeks is unnecessary.

Sovaldi and Ribavirin Cure High Rates of Those With HIV & Hep C

Jul 22, 2014: Sovaldi (sofosbuvir) and ribavirin cured between 84 percent and 91 percent of people coinfected with HIV and genotypes 1 through 4 of hepatiti...

People With HIV, Hepatitis C and Cirrhosis Can Do Very Well on Hep C Treatment

Mar 8, 2017: However, in a recent study those who had been treated for hep C before did not fare as well.

Major Disparities Seen in Hep C Treatment Uptake Among Canadians With HIV

Mar 10, 2017: HIV/HCV-positive women and indigenous people are much less likely to receive treatment for hep C.

Sovaldi & Ribavirin Is Effective for HIV/HCV Population

Mar 24, 2014: Sovaldi and ribavirin cured 75 percent of those with genotype 1 of hepatitis C in a recent trial

Sofosbuvir and Ribavirin Fare Well Among HIV-HCV Coinfected

Nov 4, 2013: Sofosbuvir and ribavirin cured between 67 and 88 percent of those coinfected with HIV and genotypes 1, 2 or 3 of hepatitis C virus in a recent...